Institutional Ownership
Rocket Pharmaceuticals Inc
CUSIP 77313F106COMRCKTQ1 2026
13D / 13G Filings
36
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
29.3%
Max % of class reported
Institutional Holders
191
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
36 filings · latest Feb 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2026 | Maverick Capital, Ltd. | 13G/A | 2.3% | 2.51M | SEC |
| 2 | Jan 30, 2026 | The Vanguard Group | 13G/A | 7.9% | 8.54M | SEC |
| 3 | Aug 14, 2025 | Maverick Capital, Ltd. | 13G/A | 7.8% | 8.36M | SEC |
| 4 | Jun 5, 2025 | Wellington Management Group LLP | 13G/A | 0.9% | 1.00M | SEC |
| 5 | May 7, 2025 | Wellington Management Group LLP | 13G/A | 6.7% | 7.15M | SEC |
| 6 | May 7, 2025 | Wellington Management Group LLP | 13G/A | 11.8% | 12.63M | SEC |
| 7 | Apr 14, 2025 | Maverick Capital, Ltd. | 13G | 5.2% | 5.55M | SEC |
| 8 | Feb 10, 2025 | Wellington Management Group LLP | 13G/A | 13.4% | 14.00M | SEC |
| 9 | Dec 16, 2024 | Rtw Investments, LP | 13D/A | 17.4% | 18.19M | SEC |
| 10 | Nov 8, 2024 | Wellington Management Group LLP | 13G/A | 12.4% | 11.24M | SEC |
26 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Rocket Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Rtw Investments, LP | 17.69M | $63.32M |
| 2 | Blackrock, Inc. | 7.83M | $28.05M |
| 3 | Citigroup Inc | 5.11M | $18.29M |
| 4 | State Street Corp | 4.49M | $16.06M |
| 5 | Maverick Capital Ltd | 3.57M | $12.77M |
| 6 | Newtyn Management, LLC | 3.17M | $11.33M |
| 7 | Nuveen, LLC | 3.13M | $11.20M |
| 8 | Millennium Management LLC | 3.12M | $11.16M |
| 9 | Aqr Capital Management LLC | 3.07M | $10.99M |
| 10 | Marshall Wace, LLP | 3.04M | $10.88M |